189 Publications (Page 6 of 8)
2011
The emerging role of electronic medical records in pharmacogenomics.
Wilke, RussellXu, HDenny, J CRoden, D MKrauss, R MMc Carty, C ADavis, R LSkaar, TLamba, Jatinder K and Savova, G
Clinical pharmacology and therapeutics, vol. 89, (no. 3), pp. 379-86, 2011/Mar. | Journal Article
2010
Abstract 3604: Significant effect of polymorphisms in CYP2D6 and DT-1 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients
Zembutsu, HitoshiZembutsu, HitoshiKiyotani, KazumaKiyotani, KazumaMushiroda, TaiseiMushiroda, TaiseiImamura, Chiyo KImamura, Chiyo KHosono, NaoyaHosono, NaoyaKubo, MichiakiKubo, MichiakiTanigawara, YusukeTanigawara, YusukeFlockhart, David AFlockhart, David ASkaar, Todd CSkaar, Todd CDesta, ZeruesenayDesta, ZeruesenayAki, FuminoriAki, FuminoriHirata, KoichiHirata, KoichiTakatsuka, YuichiTakatsuka, YuichiOkazaki, MinoruOkazaki, MinoruOhsumi, ShozoOhsumi, ShozoYamakawa, TakashiYamakawa, TakashiSasa, MitsunoriSasa, MitsunoriNakamura, Yusuke and Nakamura, Yusuke
Cancer Research, vol. 70, (no. 8 Supplement), pp. 3604, 2010-04-15. | Journal Article
 
Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients.
Borges, SilvanaDesta, ZeruesenayJin, YanFaouzi, AzzouzRobarge, Jason DPhilips, SanoshNguyen, AnneStearns, VeredHayes, Daniel FRae, JamesSkaar, Todd CFlockhart, David A and Li, Lang
Journal of clinical pharmacology, vol. 50, (no. 4), pp. 450-8, 2010/Apr. | Journal Article
 
Differential quantification of CYP2D6 gene copy number by four different quantitative real-time PCR assays.
Ramamoorthy, AnuradhaFlockhart, David AHosono, NaoyaKubo, MichiakiNakamura, Yusuke and Skaar, Todd C
Pharmacogenetics and genomics, vol. 20, (no. 7), pp. 451-4, 2010/Jul. | Journal Article
 
Estrogen receptor genotypes, menopausal status, and the effects of tamoxifen on lipid levels: revised and updated results.
Hayes, Daniel FSkaar, T CRae, JamesHenry, Norah LNguyen, A TStearns, VLi, LPhilips, SDesta, Z and Flockhart, D A
Clinical pharmacology and therapeutics, vol. 88, (no. 5), pp. 626-9, 2010/Nov. | Journal Article
 
Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study.
Kreutz, Rolf PKreutz, Rolf PStanek, Eric JStanek, Eric JAubert, RonaldAubert, RonaldYao, JianyingYao, JianyingBreall, Jeffrey ABreall, Jeffrey ADesta, ZeruesenayDesta, ZeruesenaySkaar, Todd CSkaar, Todd CTeagarden, J RTeagarden, J. RussellFrueh, Felix WFrueh, Felix WEpstein, Robert SEpstein, Robert SFlockhart, David A and Flockhart, David A
Pharmacotherapy, vol. 30, (no. 8), pp. 787-96, 2010/Aug. | Journal Article
 
Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy.
Henry, Norah LNguyen, AAzzouz, FLi, LRobarge, JPhilips, SCao, DSkaar, T CRae, JamesStorniolo, A MFlockhart, D AHayes, Daniel F and Stearns, V
British journal of cancer, vol. 102, (no. 2), pp. 294-300, 2010/Jan/19. | Journal Article
 
Resequencing of the vascular endothelial growth factor promoter reveals haplotype structure and functional diversity.
Radovich, MilanHancock, Bradley AKassem, NawalMi, DemingSkaar, Todd C and Schneider, Bryan P
Angiogenesis, vol. 13, (no. 3), pp. 211-8, 2010/Sep. | Journal Article
 
Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients.
Kiyotani, KazumaKiyotani, KazumaMushiroda, TaiseiMushiroda, TaiseiImamura, ChiyoImamura, Chiyo KHosono, NaoyaHosono, NaoyaTsunoda, TatsuhikoTsunoda, TatsuhikoKubo, MichiakiKubo, MichiakiTanigawara, YusukeTanigawara, YusukeFlockhart, David AFlockhart, DavidDesta, ZeruesenayDesta, ZeruesenaySkaar, Todd CSkaar, ToddAki, FuminoriAki, FuminoriHirata, KoichiHirata, KoichiTakatsuka, YuichiTakatsuka, YuichiOkazaki, MinoruOkazaki, MinoruOhsumi, ShozoOhsumi, ShozoYamakawa, TakashiYamakawa, TakashiSasa, MitsunoriSasa, MitsunoriNakamura, YusukeNakamura, YusukeZembutsu, Hitoshi and Zembutsu, Hitoshi
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 28, (no. 8), pp. 1287-93, 2010/Mar/10. | Journal Article
2009
Antiestrogen pathway (aromatase inhibitor).
Desta, ZeruesenayNguyen, AnneFlockhart, David ASkaar, Todd CFletcher, RebeccaWeinshilboum, Richard MBerlin, Dorit SKlein, Teri E and Altman, Russ B
Pharmacogenetics and genomics, vol. 19, (no. 7), pp. 554-5, 2009/Jul. | Journal Article
 
A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67.
Hahn, NoahZon, R TYu, MAdemuyiwa, Foluso OJones, TDugan, WWhalen, CShanmugam, RSkaar, T and Sweeney, Christopher J
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, vol. 20, (no. 12), pp. 1971-6, 2009/Dec. | Journal Article
 
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort.
Henry, N LynnHenry, Norah LRae, JamesRae, James MLi, LangLi, LangAzzouz, FaouziAzzouz, FaouziSkaar, Todd CSkaar, Todd CDesta, ZereunesayDesta, ZereunesaySikora, Matthew JSikora, Matthew JPhilips, SantoshPhilips, SantoshNguyen, Anne TNguyen, Anne TStorniolo, Anna MariaStorniolo, Anna MHayes, Daniel FHayes, Daniel FFlockhart, David AFlockhart, David AStearns, Vered and Stearns, Vered
Breast cancer research and treatment, vol. 117, (no. 3), pp. 571-5, 2009/Oct. | Journal Article
 
Clinically available pharmacogenomics tests.
Flockhart, David ASkaar, TBerlin, D SKlein, T E and Nguyen, A T
Clinical pharmacology and therapeutics, vol. 86, (no. 1), pp. 109-13, 2009/Jul. | Journal Article
 
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients.
Rae, JamesSikora, M JHenry, Norah LLi, LKim, SOesterreich, SteffiSkaar, Todd CNguyen, A TDesta, ZeruesenayStorniolo, Anna MFlockhart, David AHayes, Daniel F and Stearns, Vered
The pharmacogenomics journal, vol. 9, (no. 4), pp. 258-64, 2009/Aug. | Journal Article
 
Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy
Onitilo, Adedayo AMc Carty, Catherine AWilke, RussellGlurich, IngridEngel, Jessica MFlockhart, David ANguyen, AnneLi, LangMi, DemingSkaar, Todd and Jin, Yan
Breast cancer research and treatment., vol. 115, (no. 3), pp. 643-650, 2009. | Journal Article
 
Evaluating the role of serotonin in hot flashes after breast cancer using acute tryptophan depletion.
Carpenter, Janet SCarpenter, JanetCarpenter, JanetYu, MenggangYu, MenggangYu, MenggangWu, JingweiWu, JingweiWu, JingweiVon Ah, DianeVon Ah, DianeVon Ah, DianeMilata, JenniferMilata, JenniferMilata, JenniferOtte, JulieOtte, Julie LOtte, JulieJohns, ShelleyJohns, ShelleyJohns, ShelleySchneider, Bryan PSchneider, BryanSchneider, BryanStorniolo, AnnaStorniolo, AnnaStorniolo, Anna MSalomon, RonaldSalomon, RonaldSalomon, RonaldDesta, ZeuresenayDesta, ZeuresenayDesta, ZeuresenayCao, DonghuaCao, DonghuaCao, DonghuaJin, YanJin, YanJin, YanPhilips, SantoshPhilips, SantoshPhilips, SantoshSkaar, Todd CSkaar, Todd and Skaar, Todd
Menopause (New York, N.Y.), vol. 16, (no. 4), pp. 644-52, 2009 Jul-Aug. | Journal Article
 
Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes
Schneider, Bryan PRadovich, MilanFlockhart, David ACarpenter, Janet SLi, LangRobarge, Jason DStorniolo, Anna MHancock, Bradley ASkaar, Todd and Sledge, George W
Breast Cancer Research and Treatment, vol. 116, (no. 3), pp. 543-9, Aug 2009. | Journal Article
 
Identification of genetic variants in the human indoleamine 2,3-dioxygenase (IDO1) gene, which have altered enzyme activity.
Arefayene, MillionArefayene, MillionPhilips, SantoshPhilips, SantoshCao, DonghuaCao, DonghuaMamidipalli, SudharaniMamidipalli, SudharaniDesta, ZeruesenayDesta, ZeruesenayFlockhart, David AFlockhart, DavidWilkes, DavidWilkes, David SSkaar, Todd C and Skaar, Todd
Pharmacogenetics and genomics, vol. 19, (no. 6), pp. 464-76, 2009/Jun. | Journal Article
 
Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
Hartmaier, Ryan JTchatchou, SandrineRichter, Alexandra SWang, JayMc Guire, Sean ESkaar, Todd CRae, Jimmy MHemminki, KariSutter, ChristianDitsch, NinaBugert, PeterWeber, Bernhard HNiederacher, DieterArnold, NorbertVaron-Mateeva, RaymondaWappenschmidt, BarbaraSchmutzler, Rita KMeindl, AlfonsBartram, Claus RBurwinkel, Barbara and Oesterreich, Steffi
BMC Cancer, vol. 9, pp. 438-438, 2009. | Journal Article
 
Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition.
Mukherjee, PinkuBasu, Gargi DTinder, Teresa LSubramani, Durai BBradley, Judy MArefayene, MillionSkaar, Todd C and De Petris, Giovanni
Journal of immunology (Baltimore, Md. : 1950), vol. 182, (no. 1), pp. 216-24, 2009/Jan/1. | Journal Article
2008
A mixture model approach in gene-gene and gene-environmental interactions for binary phenotypes.
Li, LangYu, MenggangJason, Robarge DShen, ChangyuAzzouz, FaouziMc Leod, Howard LBorges-Gonzales, SilvanaNguyen, AnneSkaar, Todd CDesta, ZeruesenaySweeney, Christopher J and Flockhart, David A
Journal of biopharmaceutical statistics, vol. 18, (no. 6), pp. 1150-77, 2008. | Journal Article
 
Association of polymorphisms of angiogenesis genes with breast cancer
Schneider, Bryan PRadovich, MilanSledge, George WRobarge, Jason DLi, LangStorniolo, Anna MLemler, SuzanneNguyen, Anne THancock, Bradley AStout, MichaelSkaar, Todd and Flockhart, David A
Breast Cancer Research and Treatment, vol. 111, (no. 1), pp. 157-63, Sep 2008. | Journal Article
 
Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy.
Jin, YanJin, YanJin, YanHayes, DanielHayes, Daniel FHayes, DanielLi, LangLi, LangLi, LangRobarge, Jason DRobarge, JasonRobarge, JasonSkaar, Todd CSkaar, ToddSkaar, ToddPhilips, SantoshPhilips, SantoshPhilips, SantoshNguyen, AnneNguyen, AnneNguyen, AnneSchott, AnneSchott, AnneSchott, AnneHayden, JillHayden, JillHayden, JillLemler, SuzanneLemler, SuzanneLemler, SuzanneStorniolo, AnnaStorniolo, AnnaStorniolo, Anna MFlockhart, DavidFlockhart, DavidFlockhart, David AStearns, VeredStearns, Vered and Stearns, Vered
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 26, (no. 36), pp. 5849-54, 2008/Dec/20. | Journal Article
 
Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen.
Ntukidem, N INguyen, A TStearns, VeredRehman, MSchott, ASkaar, Todd CJin, YBlanche, PLi, LLemler, SHayden, JKrauss, Ronald MDesta, ZFlockhart, D A and Hayes, Daniel F
Clinical pharmacology and therapeutics, vol. 83, (no. 5), pp. 702-10, 2008/May. | Journal Article
 
MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.
Tinder, Teresa LSubramani, Durai BBasu, Gargi DBradley, Judy MSchettini, JorgeMillion, ArefayeneSkaar, Todd C and Mukherjee, Pinku
Journal of immunology (Baltimore, Md. : 1950), vol. 181, (no. 5), pp. 3116-25, 2008/Sep/1. | Journal Article